#Japan #Tokyo #Euphoria #Sysmex #Health Integration

Euphoria Partners with Sysmex for Healthcare and Sports Tech Revolution

In a significant move to enhance health and performance management, Euphoria, a prominent sports tech company based in Chiyoda, Tokyo, has entered into a capital and business alliance with Sysmex, a global leader in the field of specimen testing headquartered in Kobe, Hyogo. This partnership seeks to combine their assets to foster health improvement and develop innovative solutions that integrate biological and sports behavioral data.

Background and Objectives: Optimizing the HealthCare Journey through Data Integration

The rise of data-driven condition management in sports settings and corporate health management underscores its vital importance. However, the fragmentation between daily behavioral and exercise data versus reliable biological data obtained from medical institutions presents challenges in comprehensive individual evaluations and decision-making. Euphoria has supported athlete performance enhancement through its condition management system, ONE TAP SPORTS, and has recently expanded its expertise into corporate health management services, leading the charge in accumulating and utilizing daily health data.

On the other hand, Sysmex stands out as a leading company in the specimen testing sector, possessing advanced testing technologies and analytical insights. They aim to optimize what they refer to as the "Healthcare Journey" by promoting health improvement and expanding into the sports domain using Point-of-Care Testing (POCT) technology. The partnership seeks to seamlessly connect the internal bodily conditions with daily activities, benefiting not only athletes but also the general public in maximizing their potential.

Collaborative Efforts by Both Companies

Both companies will widen their scope from sports to general wellness, promoting the following initiatives:

1. Creation of New Value Standards through Joint Research
They will conduct joint research and validation experiments on the correlation between biological data and performance or health status, aiming to develop new value standards that fuse sports science with medicine. Additionally, they will establish evaluation models tailored to different sports and domains, creating methods for objectively visualizing and assessing individual conditions.

2. Solution Development and Dissemination via ONE TAP SPORTS
Collaborating with Sysmex’s POCT devices, the data platform of Euphoria, ONE TAP SPORTS, will undergo validation experiments to develop specific solutions. This initiative aims to empower individuals and athletes to understand their health status based on scientific evidence and encourages proactive behavior modification.

3. Exploration of Future AI Utilization
There are plans to explore the analysis of accumulated data and potential use of Euphoria’s unique multi-agent AI, QUARIA AI, for personalized health experiences in the future. The goal is to automatically generate optimal advice tailored to the individual’s state.

Through this robust partnership, both companies aspire to contribute to a society where sports medicine and health seamlessly connect, allowing everyone to achieve their optimal health and performance.

About Sysmex Corporation and Euphoria, Inc.

Sysmex Corporation is engaged in the healthcare evolution since 1968, focusing on specimen testing with over 190 operating countries. With their motto of “Designing the Evolution of Healthcare,” Sysmex seeks continuous innovation in specimen testing and efforts in new domains.

Euphoria, Inc., established in 2008, is committed to enhancing encounters between people and sports. They provide various services aimed at resolving challenges in sports through technology, including condition management systems and health management for organizations.

With their aligned visions, Euphoria and Sysmex are set to unveil a new chapter in health and sports technology, fostering healthier lifestyles for individuals globally.